Cargando…
NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765650/ http://dx.doi.org/10.1186/2050-6511-14-S1-P72 |
_version_ | 1782283359159844864 |
---|---|
author | Thatcher, Gregory RJ Luo, Jia VandeVrede, Lawren Qin, Zhihui Lee, Sue Abdelhamid, Ramy Bennett, Brian M Jo LaDu, Mary Tai, Leon Larson, John |
author_facet | Thatcher, Gregory RJ Luo, Jia VandeVrede, Lawren Qin, Zhihui Lee, Sue Abdelhamid, Ramy Bennett, Brian M Jo LaDu, Mary Tai, Leon Larson, John |
author_sort | Thatcher, Gregory RJ |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3765650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37656502013-09-11 NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease Thatcher, Gregory RJ Luo, Jia VandeVrede, Lawren Qin, Zhihui Lee, Sue Abdelhamid, Ramy Bennett, Brian M Jo LaDu, Mary Tai, Leon Larson, John BMC Pharmacol Toxicol Poster Presentation BioMed Central 2013-08-29 /pmc/articles/PMC3765650/ http://dx.doi.org/10.1186/2050-6511-14-S1-P72 Text en Copyright © 2013 Thatcher et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Thatcher, Gregory RJ Luo, Jia VandeVrede, Lawren Qin, Zhihui Lee, Sue Abdelhamid, Ramy Bennett, Brian M Jo LaDu, Mary Tai, Leon Larson, John NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease |
title | NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease |
title_full | NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease |
title_fullStr | NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease |
title_full_unstemmed | NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease |
title_short | NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease |
title_sort | no/cgmp/pcreb re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of alzheimer’s disease |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765650/ http://dx.doi.org/10.1186/2050-6511-14-S1-P72 |
work_keys_str_mv | AT thatchergregoryrj nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT luojia nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT vandevredelawren nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT qinzhihui nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT leesue nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT abdelhamidramy nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT bennettbrianm nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT joladumary nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT taileon nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease AT larsonjohn nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease |